More recent studies performed using CRISPR-Cas9 mutagenesis screening of metabolism associated factors, showed that MCPIP1-deficient CD8-positive T cells are reprogrammed to long-lived effector cells with extensive accumulation, better persistence and robust effector function in tumours [78]. The gene discussed is ZC3H12A; the disease is neoplasm.